Skip to main content
. 2022 Jun 8;7(11):e149741. doi: 10.1172/jci.insight.149741

Figure 7. ApoBKTTKQSFDL pentamer.

Figure 7

(A) Binding scores of P210 epitope sequences listed in Table 2 from REVEAL binding assay. Representative plot of PBMCs from an HLA-A*02:01+ volunteer stained with (B) HLA-A*02:01 control pentamer or (C) ApoBKTTKQSFDL pentamer, (D) with backgating in magenta. (E) ApoBKTTKQSFDL pentamer+CD8+ T cells in PBMCs of HLA-A*02:01+ volunteers compared with control HLA-A*02:01 pentamer (n = 10). (F) Aliquots available from 8 of the same volunteers were stimulated with 20 μg/mL P210 peptide or vehicle (sterile double-distilled H2O) for 5 days. Representative scatterplot of vehicle (G) or P210 peptide (H) sample stained with ApoBKTTKQSFDL pentamer. (I) The P210-stimulated samples were also stained with HLA-A*02:01 control pentamer as reference for pentamer specificity. *P < 0.05 by 2-tailed t test.